Cargando…
Cannabidiol versus placebo as adjunctive treatment in early psychosis: study protocol for randomized controlled trial
BACKGROUND: Psychotic disorders are a leading cause of disability in young adults. Antipsychotics have been the primary intervention for psychosis for over 60 years, and yet, we have made little progress in treating negative symptoms, neurocognition, and functional disability. There is growing evide...
Autores principales: | Dixon, T., Cadenhead, K. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691114/ https://www.ncbi.nlm.nih.gov/pubmed/38037108 http://dx.doi.org/10.1186/s13063-023-07789-w |
Ejemplares similares
-
Cannabidiol versus risperidone for treatment of recent-onset psychosis with comorbid cannabis use: study protocol for a randomized controlled clinical trial
por: Rasmussen, Jesper Østrup, et al.
Publicado: (2021) -
The efficacy of sodium benzoate as an adjunctive treatment in early psychosis - CADENCE-BZ: study protocol for a randomized controlled trial
por: Ryan, Alex, et al.
Publicado: (2017) -
Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial
por: Cheng, Matthew P., et al.
Publicado: (2018) -
ENACT: a protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first-episode psychosis
por: Cotton, S. M., et al.
Publicado: (2019) -
Minocycline as adjunctive treatment for treatment-resistant depression: study protocol for a double blind, placebo-controlled, randomized trial (MINDEP2)
por: Husain, Muhammad Ishrat, et al.
Publicado: (2020)